| Title |
Author |
Type |
Date |
Words |
| Spontaneous Pneumomediastinum in a Critically Ill Patient with Influenza A (H1N1) Virus. |
May, Faten; Maamouri, Hela; Henry, Christophe |
|
Jun 1, 2021 |
679 |
| Coronavirus Disease 2019 and Antibiotic Stewardship--Antibiotic Usage in Adult Patients: Is It Necessary? When Should It be Concerned?. |
Onal, Ugur; Akalin, Halis |
|
Jun 1, 2021 |
4842 |
| Corticosteroids in critical COVID-19: Are all corticosteroids equal? |
Plessis, E.M.du; Lalla, U.; Allwood, B.W.; Louw, E.H.; Nortje, A.; Parker, A.; Taljaard, J.J.; Ayele |
|
Jun 1, 2021 |
3319 |
| Alternative Treatment Method for Novel Coronavirus Disease 2019: Coupled Plasma Filtration Adsorption. |
Ciftci, Bahadir; Erdogan, Cem; Kizilaslan, Deniz; Ekinci, Mursel; Olmuscelik, Oktay; Atalay, Yunus O |
|
Jun 1, 2021 |
986 |
| Veru reports Q2 EPS (4c), consensus (4c). |
|
Financial report |
May 12, 2021 |
221 |
| Peroxitech Therapeutics Secures Seed Financing to Advance New Treatment of Acute Lung Injury. |
|
|
May 12, 2021 |
535 |
| FDA approves Orgenesis IDE for pilot clinical trial of Tissue Genesis Icellator2. |
|
|
May 6, 2021 |
184 |
| Aggressive thromboprophylaxis improves clinical process and decreases the need of Intensive Care Unit in Covid-19. |
Murat Ugur, Esra Adiyeke, Eymen Recep, Nurten Bakan and Nurettin Yiyit |
|
May 1, 2021 |
3213 |
| CLINICAL PROFILES AND OUTCOMES OF PATIENTS ADMITTED WITH MODERATE TO CRITICAL CORONAVIRUS DISEASE 2019 (COVID-19). |
Sultan Mehmood Kamran, Zill-e-Humayun, Arshad Naseem, Mehmood Hussain, Yousaf Jamal, Waqar Malik and |
|
Apr 30, 2021 |
3904 |
| SC to give cash aid to judges, court personnel for COVID-19 hospital expenses. |
|
|
Apr 28, 2021 |
246 |
| Ludovic Badoy, former NHCP executive director passes away. |
|
|
Apr 20, 2021 |
319 |
| Sorrento Therapeutics announces results of Phase 1b study of COVI-MSC treatment. |
|
|
Apr 20, 2021 |
264 |
| Covid-19 patients breathe better with prone pillow. |
|
|
Apr 8, 2021 |
834 |
| Masimo announces results of mechanically ventilated COVID-19 patients study. |
|
Clinical report |
Apr 6, 2021 |
488 |
| Kingdom logs 18th Covid death. |
|
Obituary |
Apr 4, 2021 |
269 |
| Serebral Palsili Bir Cocukta Adenoviruse Bagli Agir PARDS'nin Sidofovirle Basarili Bir Sekilde Tedavisi/Successful Treatment of Severe Adenoviral ARDS Using Cidofovir in a Case with Cerebral Palsy. |
Gün, Emrah; Kendirli, Tanil; Havan, Merve; Özcan, Serhan; Balsak, Serdar; Botan, Edin; Konca, Hatice |
Clinical report |
Apr 1, 2021 |
1980 |
| COVID-19--Associated Pulmonary Aspergillosis, March-August 2020. |
Salmanton-Garcia, Jon; Sprute, Rosanne; Stemler, Jannik; Bartoletti, Michele; Dupont, Damien; Valeri |
Report |
Apr 1, 2021 |
6771 |
| Tetra Bio-Pharma gets Health Canada approval to file clinical trial application for ARDS-003 study on coronavirus patients. |
|
|
Mar 31, 2021 |
416 |
| Foresee doses first patient in Phase 2/3 clinical trial of FP-025 for treating COVID-19 associated ARDS. |
|
Clinical report |
Mar 29, 2021 |
282 |
| Foresee doses first patient in Phase 2/3 clinical trial of FP-025 for treating COVID-19 associated ARDS. |
|
Clinical report |
Mar 29, 2021 |
283 |
| Sorrento announces updated 'positive' results of Phase 1b study of COVI-MSC. |
|
Report |
Mar 25, 2021 |
263 |
| Incyte Shows Results from the Phase 3 DEVENT Study Evaluating Ruxolitinib as a Treatment for Patients with COVID-19 Associated Acute Respiratory Distress Syndrome on Mechanical Ventilation. |
|
Clinical report |
Mar 19, 2021 |
724 |
| Incyte says DEVENT study of Ruxolitinib did not meet primary endpoint. |
|
|
Mar 18, 2021 |
324 |
| ECMO technology reports increase in virus recovery rate at King Abdullah Medical City. |
Arab News |
|
Mar 12, 2021 |
554 |
| Evgen Pharma now has the financial runway to exploit its technology after 'transformative' City fundraiser. |
|
|
Mar 10, 2021 |
1050 |
| Tanner Pharma Group launches leukine for use in patients with COVID-19 associated respiratory syndrome. |
|
|
Mar 9, 2021 |
184 |
| Tanner Pharma Group launches leukine for use in patients with COVID-19 associated respiratory syndrome. |
|
|
Mar 9, 2021 |
183 |
| Para Infectious Guillain-Barre Syndrome [GBS) in Covid-19 A Case Report. |
Lahole, Swapnil; Acharya, Sourya; Raisinghani, Nitin; Kumar, Sunil; Ghule, Aishwarya |
|
Mar 1, 2021 |
1460 |
| Self-Proning in Non-Intubated Patients with COVID-19: A Strategy to Avoid Intubation. |
Powers, Jan; Chubinski, Sue; Kadenko-Monirian, Michele; Schultz, Stephani; Lung, Christina; Carman, |
Report |
Mar 1, 2021 |
3875 |
| PLASMODIUM VIVAX MALARIA: CLINICAL COURSE AND FREQUENCY OF RESISTANCE AGAINST CHLOROQUINE. |
Muhammad Asif Nizami, Adnan Khan and Sami Wahid |
|
Feb 28, 2021 |
2390 |
| Association of post-traumatic acute respiratory distress syndrome on poor prognosis: A single-center study. |
Luo Li; Tang Hao; Huang Qi; Zhu Junyu; Jiang Dongpo; Wang Bin; Sun Yu |
Report |
Feb 28, 2021 |
3021 |
| Florica Therapeutics Inc announces NSF grant to study the brain-immune axis in COVID-19. |
|
|
Feb 24, 2021 |
212 |
| Florica Therapeutics Inc announces NSF grant to study the brain-immune axis in COVID-19. |
|
|
Feb 24, 2021 |
208 |
| What are the prognostic factors affecting 30-day mortality in geriatric patients with respiratory failure in the Intensive Care Unit? |
Mustafa Ozgur Cirik and Derya Yenibertiz |
|
Feb 24, 2021 |
3761 |
| Evgen Pharma recruits over 100 patients for COVID-19 treatment study. |
|
|
Feb 18, 2021 |
397 |
| Female cop dies of COVID-19 after giving birth in a hospital. |
|
|
Feb 8, 2021 |
210 |
| Evgen Pharma updates on the +STAR' trial for Covid-19, Glioma research and key breast cancer drug. |
|
|
Jan 26, 2021 |
159 |
| OKYO Pharma says Dr Napoleone Ferrara to spearhead work on chemerin molecule to treat acute Covid symptoms; as it files patents application. |
|
|
Jan 20, 2021 |
349 |
| OKYO Pharma says Dr Napoleone Ferrara to spearhead work on chemerin molecule to treat acute Covid symptoms; as it files patents application. |
|
|
Jan 20, 2021 |
351 |
| Evgen Pharma more than half way through recruitment for its STAR-COVID 19 trial. |
|
|
Jan 20, 2021 |
283 |
| First Patient Dosed in Phase II Trial of Debiopharm's Antiviral Alisporivir Against Covid-19. |
|
|
Jan 19, 2021 |
394 |
| First Patient Dosed in its Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19. |
|
|
Jan 6, 2021 |
541 |
| Coronavirus (COVID-19) and its Relationship with Ocular Surface/Koronavirus (COVID-19) ve Okuler Yuzey ile ilickisi. |
Ekinci, Cansu; Ozdemir, Mehmet Hakan |
Report |
Jan 1, 2021 |
2604 |
| POSSIBLE THERAPEUTIC ROLE OF CHOLINERGIC AGONISTS ON COVID-19 RELATED INFLAMMATORY RESPONSE. |
Baris, Elif; Arici, M. Aylin |
|
Jan 1, 2021 |
3516 |
| EOM Pharmaceuticals Files Pre-IND Meeting Request with US FDA to Evaluate Plans for a Phase 2 Clinical Trial of Its Investigational Dual-Acting, Broad-Spectrum Immunomodulator in COVID-19 Patients. |
|
|
Dec 24, 2020 |
475 |
| Foresee Pharmaceuticals Announces Completion of US47 Million Financing. |
|
|
Dec 24, 2020 |
401 |
| Tetra Bio-Pharma poised to receive government funding to help develop potential coronavirus treatment ARDS-003. |
|
|
Dec 22, 2020 |
440 |
| Baguio City COVID-19 update: 52 new cases, 2 deaths. |
|
|
Dec 20, 2020 |
482 |
| Fast Track Designation Granted For Treatment Of ARDS/COVID-19. |
|
|
Dec 14, 2020 |
385 |
| COULD COVID-19 BE A HEMOGLOBINOPATHY?/BI LI COVID-19 MOGLA BITI HEMOGLOBINOPATIJA? |
Shakoori, Tania Ahmed; Hafeez, Muhammad Mansoor; Malik, Arif |
Report |
Dec 1, 2020 |
3354 |
| Skin symptoms common in COVID-19 'long-haulers'. |
Salamon, Maureen |
|
Dec 1, 2020 |
893 |
| Characteristics and outcomes of obstetric patients with maternal sepsis requiring admission to a South African intensive care unit: A retrospective review. |
Lafon, J.Y.; Buga, E.C.; Nethathe, G.D. |
|
Dec 1, 2020 |
4099 |
| E-Cigarette or Vaping Product Use-Associated Lung Injury: A Review for Pathologists. |
Cecchini, Matthew J.; Mukhopadhyay, Sanjay; Arrossi, Andrea V.; Beasley, Mary B.; Butt, Yasmeen M.; |
|
Dec 1, 2020 |
7236 |
| Characteristics and Outcomes of the Patients Infected with SARS-CoV-2 Admitted to Intensive Care Units: Erciyes University COVID-19 Center Experience. |
Temel, Sahin; Gundogan, Kursat; Ulger, Birkan; Arican, Huseyin; Bulut, Kadir; Sari, Ali; Sipahioglu, |
Report |
Dec 1, 2020 |
3464 |
| COVID-19 in Kazakhstan: A Fatal Case Report. |
Maukayeva, Saule; Tokayeva, Alma; Issabekova, Zhanar; Kiyebayeva, Aliya; Karimova, Saya |
Clinical report |
Dec 1, 2020 |
2092 |
| Postoperative Coronavirus Disease 2019 Infection in a Patient with Recurrent Colon Carcinoma: First Surgical Case Experience in the Pandemic/Nuks Kolon Karsinomu Olan Hastada Postoperatif Donemde COVID-19 Enfeksiyonu: Pandemideki Ilk Cerrahi Tecrubesi. |
Uludag, Server Sezgin; Gures, Nazim; Sanli, Ahmet Necati; Balkan, Ilker Inanc; Zengin, Abdullah Kaga |
|
Dec 1, 2020 |
2096 |
| Lesson Learned From an In Situ Tube Thoracostomy in Postoperative Congenital Diaphragmatic Hernia Repair: Even an Open Pneumothorax Can Be Catastrophic/Postoperatif Konjenital Diyafragmatik Herni Onariminda In Situ Tup Torakostomiden Alinan Ders: Acik Bir Pnomotoraks Bile Katastrof Olabilir. |
Arora, Prateek; Karim, Habib Md Reazaul; Singha, Subrata Kumar; Basumatary, Kartik; Borkar, Nitin Ku |
Clinical report |
Dec 1, 2020 |
1801 |
| Rapid evolution of our understanding of the pathogenesis of COVID-19--implications for therapy. |
Mustafa, F.; Giles, R.; Pepper, M.S. |
Report |
Dec 1, 2020 |
7052 |
| Companies Partner To Bring MSC Therapy For COVID-19/ARDS To Market. |
|
|
Nov 30, 2020 |
453 |
| PreveCeutical announces successful lab development of a cannabinoid Sol-Gel formulation to prevent or treat coronavirus. |
|
|
Nov 26, 2020 |
394 |
| S&P/ASX 200 rises for a fifth session in a row; up 2.5% this week. |
|
|
Nov 21, 2020 |
814 |
| Novartis Partners With Mesoblast For Remestemcel-L Manufacture. |
|
|
Nov 20, 2020 |
240 |
| AgeX Sublicenses Stem Cell LineTo Company Developing Cell Therapy For COVID-19/ARDS. |
|
|
Nov 16, 2020 |
636 |
| Baguio City logs 3rd fatality, 69 new cases on COVID-19. |
|
|
Nov 8, 2020 |
281 |
| Tetra Bio-Pharma says ARDS-003 has potential to earn $500M in revenue from royalties, upfront payments by 2026. |
|
|
Nov 5, 2020 |
479 |
| Company s MSC Program Cleared For Phase 1 Trial In COVID-19. |
|
|
Nov 2, 2020 |
215 |
| Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January-February 2020. |
Yao, Zhi; Chen, Junbo; Wang, Qianli; Liu, Weiyong; Zhang, Qi; Nan, Jing; Huang, Hai; Wu, Yuying; Li, |
Clinical report |
Nov 1, 2020 |
2937 |
| COVID-19 in Nursing Homes: The Problematic Management of Residents Without Positive COVID-19 RT-PCR. |
Bloch, Frederic |
Letter to the editor |
Nov 1, 2020 |
1070 |
| Acute cardiac injury is associated with adverse outcomes, including mortality in COVID-19 patients: A single-center experience. |
Naeem, Kashif B.; Hachim, Mahmood Y.; Hachim, Ibrahim Y.; Chkhis, Ayman; Quadros, Rajesh; Hannawi, H |
Report |
Nov 1, 2020 |
4194 |
| Clinical characteristics and in-hospital mortality of COVID-19 adult patients in Saudi Arabia. |
Abohamr, Samah I.; Abazid, Rami M.; Aldossari, Mubarak A.; Amer, Hala A.; Badhawi, Omar S.; Aljunaid |
Report |
Nov 1, 2020 |
5795 |
| Combination Therapy with Aminoglycoside in Bacteremiasdue to ESBL-Producing Enterobacteriaceae in ICU. |
Benetazzo, Lucie; Delannoy, Pierre-Yves; Houard, Marion; Wallet, Frederic; Lambiotte, Fabien; Vachee |
Clinical report |
Nov 1, 2020 |
6547 |
| Use of REBOA As an Adjunct to The Conventional Femoral Cut-Down For Bleeding Control During Veno-Arterial ECMO Decannulation. |
Ozluer, Yunus Emre; Avcil, Mucahit; Yetis, Cagac; Yasar, Kezban Seker |
Clinical report |
Nov 1, 2020 |
1356 |
| Bloodstream infections in patients undergoing extracorporeal membrane oxygenation. |
Jian-rong Wang, Jin-yu Huang, Wei Hu, Xue-ying Cai, Wei-hang Hu and Ying Zhu |
|
Oct 31, 2020 |
3901 |
| Shares In Evgen Pharma Rise On Approval For SFX-01 Trial. |
|
|
Oct 23, 2020 |
212 |
| TRI, BARDA & NIH to support the ACTIV-1 IM study for treating COVID-19. |
|
Clinical report |
Oct 21, 2020 |
297 |
| TRI, BARDA & NIH to support the ACTIV-1 IM study for treating COVID-19. |
|
Clinical report |
Oct 21, 2020 |
301 |
| Pluristem announces formation of COVID-19 Steering Committee. |
|
|
Oct 20, 2020 |
326 |
| Baguio City posts 20th COVID-19 fatality. |
|
|
Oct 19, 2020 |
254 |
| Phase 2 COVID-19 European Clinical Trial Expanded To Israel. |
|
|
Oct 19, 2020 |
398 |
| Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome and Other Acute Respiratory Conditions. |
|
|
Oct 14, 2020 |
211 |
| Direct Biologics wins FDA expanded access protocol for ExoFlo for the treatment of COVID-19. |
|
|
Oct 14, 2020 |
220 |
| Direct Biologics wins FDA expanded access protocol for ExoFlo for the treatment of COVID-19. |
|
|
Oct 14, 2020 |
224 |
| Sorrento Therapeutics enters exclusive license agreement with PSC for MSC rights. |
|
Clinical report |
Oct 12, 2020 |
271 |
| Pluristem receives approval to commence patient enrollment in COVID-19 trial. |
|
|
Oct 7, 2020 |
162 |
| FibroGenesis partners with Brazil's R4D Biotech for the advanced development of PneumoBlast cell therapy in the treatment of COVID-19. |
|
|
Oct 5, 2020 |
215 |
| FibroGenesis partners with Brazil's R4D Biotech for the advanced development of PneumoBlast cell therapy in the treatment of COVID-19. |
|
|
Oct 5, 2020 |
219 |
| RMAT Designation Granted To MultiStem Cell Theraoy For ARDS. |
|
|
Oct 5, 2020 |
415 |
| FibroGenesis partners with Brazil's R4D Biotech to develop PneumoBlast cell therapy to treat ARDS & COVID-19. |
|
|
Oct 2, 2020 |
186 |
| FibroGenesis partners with Brazil's R4D Biotech to develop PneumoBlast cell therapy to treat ARDS & COVID-19. |
|
|
Oct 2, 2020 |
190 |
| Avalon expands AVA-001 trial to non-Hodgkin lymphoma patients; plans acute respiratory distress syndrome trial for later this year. |
|
|
Oct 2, 2020 |
436 |
| Human Adenovirus B7d--Associated Urethritis after Suspected Sexual Transmission, Japan. |
Hanaoka, Nozomu; Ito, Shin; Nojiri, Naomi; Konagaya, Masami; Yasuda, Mitsuru; Deguchi, Takashi; Fuji |
|
Oct 1, 2020 |
1986 |
| The Review of Histopathological Pulmonary Findings of COVID-19: What We Learned from Postmortem Biopsy and Autopsies; Beyond the Horizon. |
Ozmen, Sevilay Akalp; Ceylan, Onur; Demirag, Funda; Araz, Omer |
Letter to the editor |
Oct 1, 2020 |
1261 |
| Clinical management of COVID-19: Experiences of the COVID-19 epidemic from Groote Schuur Hospital, Cape Town, South Africa. |
Mendelson, M.; Boloko, L.; Boutall, A.; Cairncross, L.; Calligaro, G.; Coccia, C.; Dave, J.A.; de Vi |
Report |
Oct 1, 2020 |
6410 |
| The Effect of Therapeutic Plasma Exchange on COVID-19 Therapy/Terapotik Plazma Degisiminin COVID-19 Tedavisine Etkisi. |
Goncuoglu, Cansu; Balli, Fatma Nisa; Ekincioglu, Aygin Bayraktar |
Letter to the editor |
Oct 1, 2020 |
1064 |
| FDA Accepts Windtree IND Application for a Phase 2 Clinical Trial Studying KL4 Surfactant in Acute Lung Injury in Adults with COVID-19. |
|
|
Sep 29, 2020 |
563 |
| What to do when you may have breathed in too much smoke. |
|
|
Sep 24, 2020 |
876 |
| FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome. |
|
|
Sep 23, 2020 |
587 |
| Board UrgesContinuation Of Phase 3 Trial In COVID-19/AKUS patients. |
|
|
Sep 21, 2020 |
246 |
| AVM Biotechnology receives second IND for AVM0703 to treat COVID-19 and Influenza ARDS with supercharged version of dexamethasone. |
|
|
Sep 17, 2020 |
225 |
| FDA grants approval to AVM Biotechnology to proceed with AVM0703 clinical trials. |
|
|
Sep 17, 2020 |
152 |
| Memorial Hermann performs double lung transplant on 70 year patient whose lungs were damaged by COVID-19. |
|
|
Sep 17, 2020 |
259 |
| AVM Biotechnology receives second IND for AVM0703 to treat COVID-19 and Influenza ARDS with supercharged version of dexamethasone. |
|
|
Sep 17, 2020 |
221 |
| Memorial Hermann performs double lung transplant on 70 year patient whose lungs were damaged by COVID-19. |
|
|
Sep 17, 2020 |
263 |
| Relief Therapeutics expects top-line trial results for COVID-19 treatment in early Q4 2020. |
|
|
Sep 15, 2020 |
190 |
| Relief Therapeutics expects top-line trial results for COVID-19 treatment in early Q4 2020. |
|
|
Sep 15, 2020 |
194 |
| Humanigen And Lonza Team To Expand Manufacturing Of Covid-19 Treatment. |
|
|
Sep 15, 2020 |
188 |
| Bioclinica & Direct Biologics partnership to provide Interactive Response Technology Solution for COVID-19 Study. |
|
|
Sep 10, 2020 |
164 |
| Bioclinica & Direct Biologics partnership to provide Interactive Response Technology Solution for COVID-19 Study. |
|
|
Sep 10, 2020 |
168 |
| This hyperactive hormone may be deadly in COVID-19 patients. |
|
|
Sep 8, 2020 |
814 |
| FDA Clears PI uri stem's COVID Expanded Access Program: Approval Enables Patient Treatment Outside Of Clinical Trial. |
|
|
Sep 7, 2020 |
594 |
| Patient Enrolment Opens In COVID-19 Clinical Trial. |
|
|
Sep 7, 2020 |
236 |
| Mesoblast says DSMB recommends continuation of remestemcel-L Phase 3 trial. |
|
|
Sep 4, 2020 |
185 |
| First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients. |
|
|
Sep 2, 2020 |
743 |
| COVID-19 in a Hispanic Woman: Autopsy Report With Clinical-Pathologic Correlation. |
Yan, Lei; Mir, Mahnoor; Sanchez, Paloma; Beg, Moeezullah; Peters, Jay; Enriquez, Omar; Gilbert, Andr |
|
Sep 1, 2020 |
5836 |
| Use of Anti-Interleukin-6 Receptor Monoclonal Antibody in Drug-Induced Acute Respiratory Distress Syndrome. |
Petrillo, Alessandra; Biran, Noa; Sadikot, Sean |
|
Aug 31, 2020 |
1892 |
| Critical Care Management for Novel 2019 SARS-CoV-2 and HcoV-NL63 Coinfection in a Young Immunocompromised Patient: A Chicago Experience. |
Sanchez-Nadales, Alejandro; Treminio-Quezada, Miguel; Abad, Hasan; Navarro-Motta, Jessica; Contreras |
|
Aug 31, 2020 |
4619 |
| Predictive Factors for Failure of Noninvasive Ventilation in Adult Intensive Care Unit: A Retrospective Clinical Study. |
Chen, Qimin; Liu, Ming; Liu, Bo; Li, Wei; Gao, Daixiu; Xie, Lulu; Wu, Yu; Li, Liang; Liu, Ying; Wang |
Clinical report |
Aug 31, 2020 |
4844 |
| Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies. |
Ojo, Ademola S.; Balogun, Simon A.; Williams, Oyeronke T.; Ojo, Olusegun S. |
|
Aug 31, 2020 |
8809 |
| Electroacupuncture Pretreatment Alleviates LPS-Induced Acute Respiratory Distress Syndrome via Regulating the PPAR Gamma/NF-Kappa B Signaling Pathway. |
Feng, Di; Zhou, Huanping; Jin, Xiaohong; Wei, Juan; Zhang, Qingqing; Gu, Yang; Zhang, Pengcheng; Yan |
|
Aug 31, 2020 |
6056 |
| Salvia miltiorrhiza Injection Alleviates LPS-Induced Acute Lung Injury by Adjusting the Balance of MMPs/TIMPs Ratio. |
Chen, Guobing; Ge, Dandan; Zhu, Bizhen; Shi, Huixuan; Ma, Qilin |
|
Aug 31, 2020 |
5358 |
| EFFECT OF COVID-19 ON LIVER FUNCTION TESTS; RESULT FROM A TERTIARY CARE HOSPITAL IN PAKISTAN. |
Rashk e Hinna, Samina Fida, Muhammad Asif Farooq, Asma Asghar, Muhammad Uzair and Talha Rehman Zahid |
|
Aug 31, 2020 |
2944 |
| PERCEPTION OF RISK OF EXPOSURE TO SARS-COV-2 (COVID-19) IN DIFFERENT SECTORS OF HEALTHCARE WORKERS: A CORRELATIONAL STUDY. |
Ahmed Tanveer, Rumeesha Zaheer, Amal Farooq, Maheen Khan, Abdullah Jan and Shireen Zaheer Awan |
|
Aug 31, 2020 |
4097 |
| Tiziana Life Sciences hails key US patent approval that provides added protection for COVID-19 drug. |
|
|
Aug 25, 2020 |
323 |
| Tiziana Life Sciences hails key US patent approval that provides added protection for COVID-19 drug. |
|
|
Aug 25, 2020 |
321 |
| Faron Pharmaceuticals rises after Traumakine update. |
|
|
Aug 19, 2020 |
511 |
| Vasomune Receives a USD 2.8m PRMRP Grant from the US Department of Defense to Develop AV-001 for the Treatment of ALI/ARDS of Any Cause, Including COVID-19. |
|
|
Aug 18, 2020 |
478 |
| Mouse Study Of Treatment For COVID-19 ARDS Reaches Milestone. |
|
|
Aug 10, 2020 |
351 |
| Omeros Touts Results of Study Evaluating Narsoplimab for Treatment of COVID-19-Associated Acute Respiratory Distress Syndrome. |
|
|
Aug 10, 2020 |
832 |
| Omeros reports recovery, survival of all COVID patients in study of narsoplimab. |
|
|
Aug 10, 2020 |
310 |
| 11th COVID-19 patient in Vigt Nam dies. |
|
|
Aug 9, 2020 |
255 |
| Neutrolis develops NTR-441 to clear neutrophil extracellular traps (NETs) in severe COVID-19 patients. |
|
|
Aug 4, 2020 |
196 |
| Neutrolis develops NTR-441 to clear neutrophil extracellular traps (NETs) in severe COVID-19 patients. |
|
|
Aug 4, 2020 |
192 |
| Veru says VERU-111 suppresses key cytokines for severs ARDS. |
|
|
Aug 4, 2020 |
443 |
| Transfusion-related Acute Lung Injury: A Case Report. |
Polat, Arzu Caliskan; Yigit, Yesim; Onder, Esra Nagehan Akyol; Yildirim, Aysen Turedi; Ertan, Pelin; |
|
Aug 2, 2020 |
1794 |
| Mesenchymal Stem Cell Therapy and New Approaches in COVID-19 Patients/COVID-19 Hastalarinda Mezenkimal Kok Hucre Tedavisi ve Yeni Yaklasimlar. |
Ozkan, Serbay; Koyuturk, Meral |
|
Aug 1, 2020 |
4641 |
| Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity. |
Huang, Glen; Kovalic, Alex J.; Graber, Christopher J. |
|
Aug 1, 2020 |
1797 |
| Extracorporeal Membrane Oxygenation Experience in the Patient with Acute Respiratory Distress Syndrome After Candida pneumonia/Candida Pnomonisi Sonrasi Akut Solunum Sikintisi Sendromu Hastasinda Ekstrakorporyal Membran Oksijenasyonu Deneyimi. |
Ozden, Eyyup Sabri; Ceylan, Asiye; Oral, Mehmet |
|
Aug 1, 2020 |
2203 |
| The emerging role of lung ultrasound in COVID-19 pneumonia. |
Lepri, Gemma; Orlandi, Martina; Lazzeri, Chiara; Bruni, Cosimo; Hughes, Michael; Bonizzoli, Manuela; |
|
Aug 1, 2020 |
4485 |
| Evaluation of National Early Warning System for Mortality in Hematological Malignancy Patients Admitted to Intensive Care Unit: Prospective, Single Center, Observational Study. |
Ileri, Ibrahim; Coskun, Ramazan; Temel, Sahin; Gundogan, Kursat; Sungur, Murat |
Clinical report |
Aug 1, 2020 |
3455 |
| Management of COVID-19 in intensive care units. |
Hanci, Pervin |
|
Aug 1, 2020 |
4655 |
| COVID-19 and pulmonary rehabilitation. |
Beykumul, Aysegul; Gulbas, Gazi |
|
Aug 1, 2020 |
2320 |
| Serebral Palsili Bir Cocukta Adenoviruse Bagli Agir PARDS'nin Sidofovirle Basarili Bir Sekilde Tedavisi/Succesful Treatment of Severe Adenoviral ARDS in a Case with Cerebral Palsy Using Cidofovir. |
Gun, Emrah; Kendirli, Tanil; Havan, Merve; Ozcan, Serhan; Balsak, Serdar; Botan, Edin; Konca, Hatice |
|
Aug 1, 2020 |
1944 |
| Inhibition of ERR[alpha] Aggravates Sepsis-Induced Acute Lung Injury in Rats via Provoking Inflammation and Oxidative Stress. |
Xia, Wenfang; Pan, Zhou; Zhang, Huanming; Zhou, Qingshan; Liu, Yu |
|
Jul 31, 2020 |
4856 |
| 9 Meters Biopharma issued larazotide-related patent from USPTO. |
|
|
Jul 28, 2020 |
227 |
| Arch Biopartners announces first U.S. site for Phase II trial for LSALT peptide. |
|
|
Jul 28, 2020 |
201 |
| 9 Meters Biopharma's larazotide patent positive in ALI/ARDS, says SunTrust. |
|
|
Jul 28, 2020 |
161 |
| Bubble Helmet for Non-Invasive Ventilation. |
Akhil, Jerard Jijo; Subhashkumar, M.S.; Liji, G.V.; Jnana, N.J.; Sujesh, S. |
|
Jul 25, 2020 |
4572 |
| BrainStorm reports pre-clinical study of NurOwn derived exosome-based treatment. |
|
Clinical report |
Jul 23, 2020 |
285 |
| Cerecor enrolls first patient in multicenter PoC study of CERC-002. |
|
|
Jul 21, 2020 |
276 |
| DSG Supports PhaseBio Pharmaceuticals with Unified Clinical Trial Software Platform for COVID-19 Trial. |
|
|
Jul 17, 2020 |
328 |
| Akebia to evaluate vadadustat therapy for prevention and treatment of ARDS in patients hospitalized with COVID-19. |
|
|
Jul 15, 2020 |
226 |
| Akebia to evaluate vadadustat therapy for prevention and treatment of ARDS in patients hospitalized with COVID-19. |
|
|
Jul 15, 2020 |
222 |
| Boost critical care to save lives from the virus. |
|
|
Jul 14, 2020 |
1617 |
| Equillium says itolizumab 'significantly' reduced COVID-19 mortality. |
|
|
Jul 13, 2020 |
248 |
| Citius Gets Okay To "Proceed With iMSC-Based COVID-19/ARDS Treatment. |
|
|
Jul 13, 2020 |
255 |
| Man, 60, becomes Bicol's 7th COVID-19 related death. |
|
|
Jul 11, 2020 |
226 |
| Mahmood opens state of art hospital for Corona patients. |
Tariq Saeed |
|
Jul 10, 2020 |
537 |
| KP CM inaugurates specialized COVID-19 model hospital in Peshawar. |
|
|
Jul 10, 2020 |
589 |
| KP CM inaugurates COVID hospital in City, interchange on Swat Motorway. |
|
|
Jul 9, 2020 |
818 |
| Cellenkos receives promising clinical data from Johns Hopkins University Hospital's COVID-19 Treg cell therapy; With publication in peer reviewed journal of Annals of Internal Medicine. |
|
|
Jul 7, 2020 |
273 |
| Cellenkos receives promising clinical data from Johns Hopkins University Hospital's COVID-19 Treg cell therapy; With publication in peer reviewed journal of Annals of Internal Medicine. |
|
|
Jul 7, 2020 |
277 |
| Hepion announces preclinical data supporting COVID-19 treatment with CRV431. |
|
|
Jul 7, 2020 |
414 |
| Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient. |
Blaize, Marion; Mayaux, Julien; Nabet, Cecile; Lampros, Alexandre; Marcelin, Anne-Genevieve; Thellie |
Letter to the editor |
Jul 1, 2020 |
1358 |
| Torsade de pointes caused by hydroxychloroquine use in a patient with a severe form of COVID-19. |
Zarrouki, Y.; Rebahi, H.; Rhezali, M.; Douirek, F.; Ziad, A.; Samkaoui, M.A. |
|
Jul 1, 2020 |
770 |
| Current Concepts in Community and Ventilator Associated Lower Respiratory Tract Infections in ICU Patients. |
Martin-Loeches, Ignacio |
|
Jul 1, 2020 |
5612 |
| A Narrative Review of COVID-19: The New Pandemic Disease. |
Shirani, Kiana; Sheikhbahaei, Erfan; Torkpour, Zahra; Nejad, Mazyar Ghadiri; Moghadas, Bahareh Kamya |
|
Jul 1, 2020 |
11262 |
| Analysis of Serial C-Reactive Protein Levels in Critically Ill COVID-19 Patients Receiving Tocilizumab. |
Atika Masood, Omair Farooq, Sadaf Waris, Muhammad Khan, Asim Mumtaz, Maleeha Aslam and Muhammad Usam |
Clinical report |
Jun 30, 2020 |
2747 |
| Acupoint Catgut Embedding Improves the Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats. |
Li, Dan; Sun, Tian; Chi, Laiting; Zhao, Dengming; Li, Wenzhi |
|
Jun 30, 2020 |
6755 |
| Keratinocyte Growth Factor-2 Reduces Inflammatory Response to Acute Lung Injury Induced by Oleic Acid in Rats by Regulating Key Proteins of the Wnt/[beta]-Catenin Signaling Pathway. |
Tenghao, Shao; Ning, Chen; Shenghai, Wang; Qinlong, Sun; Jiaqian, Wu; Kuo, Wang; Zhanbiao, Yu; Xigan |
|
Jun 30, 2020 |
6376 |
| Health Canada Allows COVID-19 Patients with Respiratory Failure to Be Given NuvOx Pharma's Oxygen Therapeutic in Phase IIa Clinical Trial. |
|
|
Jun 30, 2020 |
155 |
| A Rare Case of ARDS Caused by Bupropion Inhalation and Treated with Noninvasive Ventilation. |
Saiegh, Yousif Al-; Spears, Jenna; De Klerk, Pieter S.; Hitchings, Joshua; Lee, Christopher; Mahr, T |
|
Jun 30, 2020 |
1904 |
| The Use of Exogenous Lung Surfactant (Poractant Alfa) in Acute Respiratory Failure by Drowning. |
Pezzi, Mario; Givigliano, Francesco; Perrone, Ottorino; Scozzafava, Annamaria; Maglio, Pietro; Casel |
|
Jun 30, 2020 |
2762 |
| COVID-19 Lockdown: Current Situation and Challenges Facing in Pakistan During Lockdown. |
Saima Kouser, Samina Kausar and Mansoor Ghani |
|
Jun 30, 2020 |
3471 |
| Pluristem Activates Clinical Sites, Begins Enrollment In U.S. COVID-19/ARDS Trial. |
|
Clinical report |
Jun 29, 2020 |
324 |
| Citius announces FDA's response for Induced Mesenchymal Stem Cells (iMSCs) to treat ARDS in COVID-19 patients. |
|
|
Jun 29, 2020 |
217 |
| US FDA responds to Citius Pharmaceuticals' pre-investigational new drug application for induced mesenchymal stem cells for treatment of acute respiratory distress syndrome in Covid-19 patients. |
|
|
Jun 29, 2020 |
165 |
| Citius announces FDA's response for Induced Mesenchymal Stem Cells (iMSCs) to treat ARDS in COVID-19 patients. |
|
|
Jun 29, 2020 |
213 |
| US FDA responds to Citius Pharmaceuticals' pre-investigational new drug application for induced mesenchymal stem cells for treatment of acute respiratory distress syndrome in Covid-19 patients. |
|
|
Jun 29, 2020 |
161 |
| Citius Receives FDA Response on Pre-Investigational New Drug Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome in Patients with COVID-19. |
|
|
Jun 26, 2020 |
503 |
| First Patient Dosed in Phase 2 Study of TD-0903 for the Treatment of Hospitalised Patients with Acute Lung Injury Caused by COVID-19. |
|
|
Jun 25, 2020 |
672 |
| Theravance Biopharma says first COVID patient dosed in TD-0903 Phase 2 study. |
|
|
Jun 25, 2020 |
234 |
| RLF-100 Granted Fast Track Designation by the FDA for the Treatment of Respiratory Distress in COVID-19. |
|
|
Jun 24, 2020 |
774 |
| Melior Discovery Teams with SFA on Grant Directed to COVID-19. |
|
|
Jun 24, 2020 |
265 |
| Palatin to develop PL8177 as a treatment for COVID-19 patients. |
|
|
Jun 23, 2020 |
187 |
| This French priest died of suffocation on the cross in Wuhan nearly 200 years ago. |
Jay Hilotin, Assistant Editor |
|
Jun 22, 2020 |
1114 |
| Meet the Catholic priest who died of suffocation on the cross in Wuhan nearly 200 years ago. |
Jay Hilotin, Assistant Editor |
|
Jun 22, 2020 |
1112 |
| Meet the Catholic priest who died of suffocation on a cross in Wuhan nearly 200 years ago. |
Jay Hilotin, Assistant Editor |
|
Jun 22, 2020 |
1112 |
| Veru enrolls first patient in Phase 2 trial of VERU-111 for COVID-19. |
|
|
Jun 19, 2020 |
153 |
| Evgen Pharma Says SFX-01 To Be Evaluated In Covid-19 Trial. |
|
|
Jun 17, 2020 |
305 |
| COVID-19: Cancer drug may quench inflammation in severely ill patients. |
|
|
Jun 12, 2020 |
328 |
| CellResearch offers source of cGMP umbilical cord lining stem cells for COVID-19 related trials. |
|
|
Jun 11, 2020 |
154 |
| CellResearch offers source of cGMP umbilical cord lining stem cells for COVID-19 related trials. |
|
|
Jun 11, 2020 |
158 |
| Pluristem announces activation of clinical sites in Phase II COVID-19 ARDS trial. |
|
Clinical report |
Jun 11, 2020 |
155 |
| COVID-19 drugs from India, Pakista, Bangladesh: Remdesivir, camostat, avipiravir, HQC and others. |
Jay Hilotin, Assistant Editor |
|
Jun 7, 2020 |
2288 |
| Relief Therapeutics and NeuroRx Enroll First Patients with RLF- 100 in Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress. |
|
|
Jun 2, 2020 |
974 |
| Virus patients faced higher surgery risks. |
|
|
Jun 2, 2020 |
194 |
| 28-Day Follow Up Of Stem Cell Treatment Of COVID-19. |
|
|
Jun 1, 2020 |
444 |
| FDA Authorizes IND Application For Stem Cell Treatment For COVID-19. |
|
|
Jun 1, 2020 |
443 |
| Pandemic care: The need for hemostasis testing in critically ill COVID-19 patients. |
Riley, Paul |
|
Jun 1, 2020 |
1866 |
| Coronavirus disease (COVID-19) in Morocco: situation update and proposed remedial measures. |
Kahkahi, Rahal El; Moustaine, Meryama; Hafidi, Majida; Zouhair, Rachid; Errakhi, Rafik |
|
Jun 1, 2020 |
1285 |
| Possible Old Drugs for Repositioning in GOVID-19 Treatment: Combating Cytokine Storms from Haloperidol to Anti-interleukin Agents. |
Tulgar, Serkan; Ahiskalioglu, Ali; Kok, Abdulaziz; Thomas, David Terence |
Letter to the editor |
Jun 1, 2020 |
979 |
| Atypical Presentation of COVID-19: Acute Renal Failure. |
Kerget, Bugra; Akgun, Metin; Dogan, Nazim |
Letter to the editor |
Jun 1, 2020 |
1663 |
| A Rare Case of Pseudomembranous Tracheitis Presenting as Acute Stridor in a Patient after Extubation. |
Ong, Hui Yan; Ng, Jia Ji; Nadhrah, Muslim Noorain; Shaariyah, Mohamad Mokhtar; Shashi, Gopalan |
|
Jun 1, 2020 |
1175 |
| Efficacy of Amflow[R], a Real-Time-Portable Feedback Device for Delivering Appropriate Ventilation in Critically Ill Patients: A Randomised, Controlled, Cross-Over Simulation Study. |
Kim, Jong Won; Park, Sang O.; Lee, Kyeong Ryong; Hong, Dae Young; Baek, Kwang Je |
Report |
May 31, 2020 |
4806 |
| Knowledge and awareness regarding spread and prevention of COVID-19 among the young adults of Karachi. |
Mubeen, Syed Muhammad; Kamal, Shareera; Kamal, Sufiyan; Balkhi, Fizra |
Report |
May 31, 2020 |
4261 |
| COVID-19: Management. |
Mahmud, Talha; Ansarie, Mosavir |
Disease/Disorder overview |
May 31, 2020 |
2382 |
| Brain may be new therapeutic target to improve breathing following lung injury in COVID-19 patients. |
|
|
May 31, 2020 |
466 |
| Half of coronavirus patients who have surgery suffer complications; More than 50 per cent of coronavirus patients who underwent surgery suffered from post-operative pulmonary complications, a new study suggests. |
Nina Massey |
|
May 30, 2020 |
350 |
| Partner Therapeutics to evaluate Leukine in respiratory illness in patients with COVID-19 at Singapore General Hospital. |
|
|
May 29, 2020 |
238 |
| Partner Therapeutics to evaluate Leukine in respiratory illness in patients with COVID-19 at Singapore General Hospital. |
|
|
May 29, 2020 |
242 |
| Akari Therapeutics pursuing clinical study opportunities in COVID-19 pneumonia. |
|
Clinical report |
May 29, 2020 |
195 |
| Aerpio Pharmaceuticals Inc partners with Quantum Leap Healthcare Collaborative to evaluate razuprotafib for treatment of ARDS in COVID-19 patients. |
|
|
May 28, 2020 |
278 |
| Aerpio Pharmaceuticals Inc partners with Quantum Leap Healthcare Collaborative to evaluate razuprotafib for treatment of ARDS in COVID-19 patients. |
|
|
May 28, 2020 |
282 |
| Cerecor announces FDA clearance of IND for CERC-002. |
|
|
May 28, 2020 |
296 |
| Apellis initiates Phase 1/2 study of APL-9 in patients with COVID-19. |
|
|
May 28, 2020 |
230 |
| Aerpio Pharmaceuticals Collaborates with Quantum Leap to Evaluate COVID-19 Treatment. |
|
|
May 28, 2020 |
249 |
| FastForward says EMMAC Life Sciences to manufacture product for coronavirus clinical trial. |
|
|
May 27, 2020 |
532 |
| Aerpio Pharmaceuticals and Quantum Leap partner in COVID-19 ARDS trial. |
|
|
May 27, 2020 |
279 |
| NantKwest Receives FDA Authorization of IND Application for Mesenchymal Stem Cell Product for the Treatment of Severe COVID-19 Patients. |
|
|
May 19, 2020 |
421 |
| FDA .Clears Israeli Firm's IND Application For Phase 2 COVID-19 Study. |
|
|
May 18, 2020 |
440 |
| Ethics Panel .Okays. Company's Planned Clinical Trial In COVID-19. |
|
|
May 18, 2020 |
432 |
| First Patients Dosed In Trial Of Stem 'Cell Treatment For Covid-19 ARDS. |
|
|
May 18, 2020 |
410 |
| Enrollment Begins In Test Of MultiStem Cell Therapy For COVID-19/ARDS. |
|
|
May 18, 2020 |
547 |
| We're Paying A Steep Price For Not Investing In Science. |
|
|
May 17, 2020 |
604 |
| South Korean drug authority accepts Enzychem Lifesciences' Investigational New Drug application to start phase two EC-18 study. |
|
|
May 15, 2020 |
257 |
| South Korean drug authority accepts Enzychem Lifesciences' Investigational New Drug application to start phase two EC-18 study. |
|
|
May 15, 2020 |
253 |
| BioPorto in partnership awarded US$400K to test if Iloprost can improve coronavirus survival rates. |
|
|
May 15, 2020 |
459 |
| Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model. |
|
|
May 14, 2020 |
1137 |
| Pluristem provides 28-day follow up for ventilator-dependent COVID-19 patients. |
|
|
May 14, 2020 |
263 |
| Mesoblast completes financing to scale-up manufacturing of remestemcel-L. |
|
|
May 13, 2020 |
189 |
| Mesoblast jumps 15% after 1st patients dosed in remestemcel trial for COVID-19. |
|
|
May 6, 2020 |
205 |
| Relief Therapeutics' Aviptadil Enters FDA Trial at NYU Langone Health, New York, to Treat COVID-19-Induced Acute Respiratory Distress. |
|
|
May 6, 2020 |
554 |
| BioCardia announces preclincal results for anti-inflammatory cell therapy. |
|
Financial report |
May 5, 2020 |
294 |
| CohBar to target COVID-19 associated ARDS with apelin receptor agonist peptides. |
|
|
May 5, 2020 |
173 |
| Athersys Starts Patient Enrollment in the MACOVIA Study Evaluating MultiStem Cell Therapy for COVID-19 Induced ARDS. |
|
Report |
May 5, 2020 |
1020 |
| UPS supports Edwards Lifesciences' distribution of medical technologies. |
|
|
May 4, 2020 |
152 |
| 83 Percent Survival In COVID-19 Patients With Cell Therapy. |
|
|
May 4, 2020 |
290 |
| Malaria-associated pulmonary edema. |
Hage, Rene; Schuurmans, Mace M. |
|
May 1, 2020 |
1562 |
| Helmet CPAP could be a weapon in the pandemic fight. |
Jancin, Bruce |
|
May 1, 2020 |
1362 |
| Helmet CPAP could be a weapon in the pandemic fight. |
Jancin, Bruce |
|
May 1, 2020 |
1348 |
| Athersys, University Hospitals Cleveland Medical Center Activate First Clinical Site for the MACOVIA Study Evaluating MultiStem Cell Therapy for COVID-19 Induced ARDS. |
|
|
May 1, 2020 |
1107 |
| Mesoblast begins enrollment in Phase 2/3 trial of remestemcel-L. |
|
Clinical report |
Apr 30, 2020 |
186 |
| Algeron Pharmaceuticals in the spotlight with lead drug Ifenprodil as promising coronavirus therapy. |
|
|
Apr 30, 2020 |
1395 |
| Effect of Deep Sedation on Mechanical Power in Moderate to Severe Acute Respiratory Distress Syndrome: A Prospective Self-Control Study. |
Xie, Yongpeng; Cao, Lijuan; Qian, Ying; Zheng, Hui; Liu, Kexi; Li, Xiaomin |
Clinical report |
Apr 30, 2020 |
4875 |
| Prognostic Value of N-terminal Probrain Natriuretic Peptide for Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. |
Ni, Qi; Li, Chaoqian; Lin, Hua |
Report |
Apr 30, 2020 |
4555 |
| New research says football players at risk of coronavirus spread to lungs. |
Reuters News Service |
|
Apr 29, 2020 |
732 |
| Capricor: Data reports 100% survival in COVID-19 patients treated with CAP-1002. |
|
|
Apr 29, 2020 |
390 |
| Mesoblast's remestemcel-L improves survival to 83% in COVID-19 patients. |
|
|
Apr 24, 2020 |
173 |
| Biomarck Releases Phase 2a Clinical Trial Results of BIO-11006 for Acute Respiratory Distress Syndrome. |
|
Clinical report |
Apr 24, 2020 |
454 |
| FDA Grants ALung Emergency Use Authorization to the Hemolung Respiratory Assist System for the Treatment of COVID-19. |
|
|
Apr 24, 2020 |
476 |
| Theravance Biopharma says first patient dosed in Phase 1 study of TD-0903. |
|
Report |
Apr 23, 2020 |
166 |
| Alexion to initiate Phase 3 study of ULTOMIRIS with severe COVID-19 patients. |
|
|
Apr 20, 2020 |
314 |
| Edesa Biotech announces license agreement to develop COVID-19 related treatments. |
|
|
Apr 20, 2020 |
213 |
| Mesoblast To Conduct Trial Of Treatment For COVID-19-Induced ARDS. |
|
|
Apr 20, 2020 |
324 |
| Company May License Stem Cell Therapy for ARDS Associated With COVID-19. |
|
|
Apr 20, 2020 |
375 |
| Coronavirus: Regular exercise 'may protect against deadly complication', study finds; Researchers say their findings 'strongly support' the possibility that exercise can prevent, or at least reduce, acute respiratory distress syndrome -a deadly complication of coronavirus. |
By, Shivali Best |
|
Apr 16, 2020 |
329 |
| CHF Solutions says Aquadex therapy utilization increases 300% at NYC hospitals. |
|
|
Apr 16, 2020 |
180 |
| Humanigen wins FDA nod to commence Phase III study of lenzilumab in coronavirus patients. |
|
|
Apr 16, 2020 |
368 |
| CytoSorbents- CytoSorb improves outcome in pneumonia patients on ECMO. |
|
|
Apr 15, 2020 |
289 |
| CytoSorbents Corporation wins FDA emergency use authorization for CytoSorb to treat COVID-19 patients. |
|
|
Apr 14, 2020 |
198 |
| CytoSorbents Corporation wins FDA emergency use authorization for CytoSorb to treat COVID-19 patients. |
|
|
Apr 14, 2020 |
202 |
| 'I'm living proof no-one should think they are immune to this'. |
|
|
Apr 13, 2020 |
466 |
| Celularity expands collaborative license agreement with Lung Biotechnology PBC for COVID-19 treatment. |
|
|
Apr 11, 2020 |
197 |
| Celularity expands collaborative license agreement with Lung Biotechnology PBC for COVID-19 treatment. |
|
|
Apr 11, 2020 |
193 |
| United Therapeutics unit, Celularity expand collaboration to COVID-19. |
|
|
Apr 9, 2020 |
157 |
| Mesoblast to study MSC product candidate in ARDS caused by COVID-19. |
|
|
Apr 9, 2020 |
250 |
| Pluristem reports preliminary data from COVID-19 compassionate use program. |
|
|
Apr 7, 2020 |
300 |
| Australia's Mesoblast To Assess Anti-Inflammatory Stem Cell Therapy As COVID-19 Treatment. |
|
|
Apr 6, 2020 |
393 |
| Vanda Pharmaceuticals to begin FDA approved clinical trial of tradipitant in hospitalized patients with COVID-19 ARDS. |
|
|
Apr 3, 2020 |
232 |
| Vanda Pharmaceuticals to begin FDA approved clinical trial of tradipitant in hospitalized patients with COVID-19 ARDS. |
|
|
Apr 3, 2020 |
236 |
| Humanigen's lenzilumab gets FDA nod for emergency use on compassionate grounds in coronavirus patients. |
|
|
Apr 3, 2020 |
410 |
| Ampio's application for Ampion to treat COVID-19 featured in Fox News. |
|
|
Apr 2, 2020 |
201 |
| A pandemic in action: In some people, an over-reactive immune response to COVID-19 brings on severe pneumonia. |
Casey, Georgina |
|
Apr 1, 2020 |
763 |
| Fatal Disseminated Aspergillosis in a Patient with Systemic Lupus Erythematosus. |
Hardie, Rochelle; James-Goulbourne, Tracian; Rashid, Monsoon; Sullivan, Jeremy; Homsi, Yamen |
|
Mar 31, 2020 |
2717 |
| Considerations in Neuromuscular Blockade in the ICU: A Case Report and Review of the Literature. |
Workum, Jessica D.; Janssen, Stephanie H.V.; Touw, Hugo R.W. |
|
Mar 31, 2020 |
2596 |
| Early Driving Pressure Changes Predict Outcomes during Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. |
Magunia, Harry; Haeberle, Helene A.; Henn, Philipp; Mehrlander, Martin; Vlatten, Peer O.; Mirakaj, V |
|
Mar 31, 2020 |
6434 |
| Coronavirus claims seven Pakistani lives in a day. |
Ikram Junaidi |
|
Mar 31, 2020 |
794 |
| Humanigen poised to partner with leading contract research organization on Phase III trial to tackle deadly coronavirus. |
|
|
Mar 31, 2020 |
481 |
| Overexpression of Sphingosine Kinase-1 and Sphingosine-1-Phosphate Receptor-3 in Severe Plasmodium falciparum Malaria with Pulmonary Edema. |
Viriyavejakul, Parnpen; Punsawad, Chuchard |
|
Mar 31, 2020 |
4282 |
| Humanigen moves a step closer to a Phase III trial to tackle leading cause of death in coronavirus. |
|
|
Mar 28, 2020 |
364 |
| DOH: Latest deaths from COVID-19 are 14 senior citizens. |
|
|
Mar 28, 2020 |
847 |
| Cerecor to explore role of inflammatory cytokine in severe COVID-19 patients. |
|
|
Mar 26, 2020 |
179 |
| CytoSorbents' CytoSorb added to Coronavirus treatment in Italy, Panama. |
|
|
Mar 25, 2020 |
407 |
| WHO: Test symptomatic patients first. |
|
|
Mar 24, 2020 |
378 |
| First 2 COVID-19 cases detected in Myanmar. |
|
|
Mar 24, 2020 |
272 |
| Ampio prepares expanded access FDA protocol to study Ampion in ARDS. |
|
|
Mar 24, 2020 |
422 |
| Company To Evaluate Anti-Inflammatory Stem Cell Therapy Treatment Of COVID-19 Lung Disease. |
|
|
Mar 23, 2020 |
342 |
| Humanigen planning Phase III clinical trial for lenzilumab to treat coronavirus patients; shares soar. |
|
|
Mar 21, 2020 |
412 |
| BARDA designates Athersys' ARDS therapy as 'High Relevant' for COVID-19. |
|
|
Mar 19, 2020 |
395 |
| PH coronavirus cases pass 200; 3 more patients die. |
|
|
Mar 19, 2020 |
1373 |
| BREAKING: COVID-19 deaths in PH now at 17. |
|
|
Mar 18, 2020 |
437 |
| Trading suspension: Gov't response to coronavirus emergency paralyzes local stock market. |
|
|
Mar 17, 2020 |
437 |
| Pluristem says Israeli Ministry of Health approves request for PLX cells. |
|
|
Mar 17, 2020 |
325 |
| First Mindanao COVID-19 death announced by DOH. |
|
|
Mar 14, 2020 |
182 |
| DOH confirms 3 more COVID-19 deaths; total now at 5. |
|
|
Mar 13, 2020 |
210 |
| CytoSorbents sees 'potentially promising option' to help get patients out of ICU. |
|
|
Mar 12, 2020 |
351 |
| FibroGenesis submits cell therapy technology patent in the US for Coronavirus (COVID-19) ARDS. |
|
|
Mar 11, 2020 |
203 |
| FibroGenesis submits cell therapy technology patent in the US for Coronavirus (COVID-19) ARDS. |
|
|
Mar 11, 2020 |
199 |
| Faron Pharma gets US regulatory green light for late-stage trial. |
|
Clinical report |
Mar 10, 2020 |
268 |
| Proactive news snapshot: Open Orphan, Faron Pharmaceuticals, Greatland Gold... |
|
|
Mar 10, 2020 |
563 |
